Gladstone NOW: The Campaign Join Us on the Journey ✕
91 - 105 of 1427 Results Clear All
Jones lent Gladstone his time and expertise for nearly 50 years.
History Institutional News
ABC7 News—Gladstone alumnus Arye Elfenbein and his business partner, Justin Kolbeck, founded Wildtype to create cell-cultured seafood. Their company uses the same technology—known as induced pluripotent stem cells—that Elfenbein learned while working in the lab of Deepak Srivastava at Gladstone.
Gladstone Experts Srivastava Lab
An in-depth explainer about different types of vaccines and what happens in the body after vaccination.
Gladstone Experts COVID-19 Deep Dive
Chemical & Engineering News—Gladstone Investigator Jennifer Doudna is receiving the highest honor given by the American Chemical Society for discoveries on ribozyme function and CRISPR gene editing, and for her international science leadership.
Awards Gladstone Experts Doudna Lab
Gladstone unites more than 600 biologists, chemists, engineers, and data scientists, combining diverse expertise to uncover how the human body functions—and what drives disease.
Communications Gladstone Experts Institutional News
ABC7 News—Steve Finkbeiner, director of the Center for Systems and Therapeutics at Gladstone, describes the revolutionary thinking microscope that his team developed to help identify better treatments for diseases like Alzheimer’s, Parkinson’s, and ALS.
Gladstone Experts ALS Alzheimer’s Disease Parkinson’s Disease Center for Systems and Therapeutics Finkbeiner Lab
Gladstone scientists show that known genetic risk factors for neurological diseases act in the brain’s blood vessels and immune cells, revealing new targets for therapies.
News Release Research (Publication) Alzheimer’s Disease Neurological Disease Corces Lab Pollard Lab Yang Lab
Study finds strong immune defenses in pregnant and lactating women, with key benefits that could guide future vaccine design.
News Release Research (Publication) COVID-19 Infectious Disease Roan Lab
Discover Magazine—With so few Alzheimer’s drugs available, repurposing medications approved for other conditions could be the key to tackling this complex disease. In fact, Gladstone Investigator Yadong Huang and his colleagues at UCSF discovered that a combination of two cancer drugs could reduce brain degeneration and restore memory, pointing toward a potent treatment path never considered before.
Gladstone Experts Alzheimer’s Disease Huang Lab
NBC News—Gladstone Investigator Yadong Huang comments on a new study he helped lead, in which two cancer drugs showed signs of slowing or reversing symptoms of Alzheimer’s disease.
Gladstone Experts Alzheimer’s Disease Huang Lab
For World Brain Day, discover some of Gladstone’s latest breakthroughs in neurological research.
Gladstone Experts Research (Publication) Alzheimer’s Disease COVID-19 Parkinson’s Disease Neurological Disease Akassoglou Lab Corces Lab Huang Lab Mucke Lab
A new study has identified FDA-approved cancer drugs that reverse the gene expression signatures associated with Alzheimer’s.
News Release Research (Publication) Alzheimer’s Disease Neurological Disease Huang Lab
William J. Rutter, PhD, was a pioneering force in biomedicine whose vision shaped San Francisco’s Mission Bay neighborhood into a hub for innovation and discovery.
History Profile
Learn how Gladstone's location fosters enriching collaborations and partnerships.
Business Development Institutional News
Cancer Research Institute—Alex Marson, director of the Gladstone-UCSF Institute of Genomic Immunology, helps explain how AI will transform the future of cancer treatment and how scientists are shaping the next wave of progress in cancer immunotherapy.
Gladstone Experts Cancer Genomic Immunology Marson Lab
